Theraphi
The original 'plasma rejuvenation' device from the Dan Winter ecosystem — now positioned by the maker as superseded by PhiRay — explicitly traced to Antoine Priore's real French plasma research.
- The maker describes Theraphi as a broad-spectrum 'phase conjugate' plasma and ELF field device for cellular regeneration, based on the historical Priore plasma-tube approach.
- Its lineage is traced explicitly to Antoine Priore's plasma device — a real French research program reportedly studied by government scientists for cancer effects in the 1960s–70s.
- The maker cites Elizabeth Rauscher's FDA study on magnetic harmonics for pain as a correlate, and now states Theraphi is superseded by the more powerful, cheaper PhiRay.
A real, historically documented French researcher whose plasma device was studied (and controversially defunded) in mid-20th-century France — the Priore history is independently verifiable, distinct from Theraphi's own claims.
Cited across the Dan Winter product line; the Atlas has not yet independently located the specific study.
The maker's proprietary theory — not independently peer-reviewed.
EVERY SOURCE IS NAMED SO YOU CAN VERIFY IT YOURSELF. NAMING A SOURCE IS NOT ENDORSING IT.
- How accurately does Theraphi's framing represent the actual Priore history, versus adopting it as branding? (The real Priore story is well-documented and worth reading independently.)
- Where is the Elizabeth Rauscher FDA study, by citation?
- Now that the maker calls Theraphi obsolete, what is the actual recourse or upgrade path for existing owners?
Theraphi is charted as the 'legacy/previous generation' entry in the Dan Winter plasma line — its successor, PhiRay, is charted separately and explicitly positions Theraphi as superseded (a rare case of a maker retiring its own flagship on the record).
Its most interesting feature is the Priore lineage: unlike most fringe-device origin stories, Antoine Priore's plasma research genuinely happened and is documented — the open question is how faithfully that history maps onto this modern product.
SOURCE: theraphi.net (scraped 2026-07-09)
How does the real Priore history compare to Theraphi's framing of it?
The Priore program is independently documented; the Atlas is tracking a rigorous comparison of the history versus the marketing.
Report from the field →PhiRay
A $6,900 plasma-and-magnetic-field device marketed as the direct replacement for the maker's earlier Theraphi system — claimed to be 2–4x more powerful at roughly a quarter of the cost.
Plasmaphire
A battery-powered, portable pair of plasma spheres (2,500 EUR) explicitly marketed by its own maker as 'experimental' and unable to make medical claims — designed for use away from mains power, including outdoors.
Piezo Phire
The most affordable device in the Implosion Group line (700 EUR) — a piezo-based localized 'implosive charge' unit launched at the maker's own FractalU conference.